Skip to main content
Message Font: Serif | Sans-Serif
No. of Recommendations: 0

Now that applefoot is on holiday, I will keep you guys informed on our little gem.

Novogen, ASX:NRT, Nasdaq: NVGN was up 33 cent today on the news that its anti-cancer drug NV-06 was approved for phase I clinical testing. Testing will begin immediately.

The news came out only in the afternoon, it will certainly go up some more tomorrow.
Print the post Back To Top